420
Participants
Start Date
March 31, 2005
Study Completion Date
August 31, 2007
Dexmedetomidine HCL Injection
Midazolam Injection
Randwick
Blacktown
Parkville
Heidelberg
Box Hill
Hastings
Woodville
Palmerston North
Perth
Welling
Hobart
Christchurch
New York
Brooklyn
Mineola
Stoney Brook
Syracuse
Buffalo
Rochester
Monroeville
Pittsburgh
Danville
Newark
Washington D.C.
Baltimore
Lynchburg
Morgantown
Chapel Hill
Charlotte
Spartanburg
Charleston
Gordon
Augusta
Orlando
Tampa
Bay Pines
Birmingham
Memphis
Hazard
Akron
Dayton
Kettering
Flint
Iowa City
Madison
Arlington Heights
Oak Park
Peoria
Olathe
Kansas City
Omaha
Alexandria
Rogers
Olkahoma City
Houston
Galveston
Lubbock
Denver
Ogden
Chandler
Scottsdale
Pasadena
Loma Linda
Redlands
San Clemente
Palo Alto
Davis
Sacramento
Medford
Phoenix
San Francisco
San Jose
Miami
Atlanta
Indianapolis
Louisville
Shreveport
Portland
Missoula
The Bronx
Greensboro
Winston-Salem
Toledo
Dallas
Ciudad de Buenos Aires
Farmington
New Haven
Biddeford
Boston
Camden
Englewood
Porto Alegre
Porto Alegre
Pedro de Toledo
Santo André
São Paulo
Hospira, now a wholly owned subsidiary of Pfizer
INDUSTRY